Linde plc

NASDAQ:LIN

Chemicals - Specialty

Basic Materials
$512.16 -0.17%

-$0.89 today

Market cap
$235.12B
Beta
0.73
P/E (TTM)
33.5
EPS (TTM)
$15.35
Dividend yield
1.20%
52W Low $387.78High $525.87

Volume 1.37M

Average 2.28M

LIN Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Linde plcNASDAQ: LIN

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development declines year over year

Q2 FY2026 research & development of $37M fell 2.6% year over year, ahead of the -3.9% change in trailing-twelve-month research & development. Sequentially, it fell 2.6% from the prior quarter. Over 3 fiscal years it compounded at +0.9% a year.

Context

  • Research & development amounted to 0.4% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -2.6% holds above the trailing-twelve-month pace of -3.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$37M-2.6% QoQ
Last fiscal yearDec 2025
$147M-2.0% YoY
LTMJun 2026
$146M-3.9% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.6%——
1 year-2.0%——
3-year CAGR+0.9%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
147M USD
Year-over-year change
-2.0%
4-year CAGR
+0.7%

Research & Development vs competitors

How LIN compares with its peers on the latest reported figures

  • LIN's LTM Jun 2026 research & development of $146M is the highest of the 2 companies compared; the peer median is $88.9M.
  • Its year-over-year change of -3.9% is the highest of 2, against a peer median of -7.7%.
  • Research & development amounts to 0.4% of revenue for LIN, versus a peer median of 0.7%.
LIN Competitors Peer median
Research & Development for LIN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LINLinde plcLTM Jun 2026$146M -3.9%+0.9%0.4%
APDAir Products and Chemicals, Inc.LTM Sep 2026$88.9M -7.7%-5.6%0.7%
Peer median (excluding LIN) $88.9M-7.7%-5.6%0.7%

Competitors are the stored peer set for LIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue30.79B33.36B32.85B33.01B33.99B
Cost of Revenue22.18B23.65B21.31B20.92B21.15B
Gross Profit8.62B9.71B11.55B12.08B12.83B
Gross Margin28.0%29.1%35.1%36.6%37.8%
Research & Development143M143M146M150M147M
Selling, General & Admin3.19B3.11B3.3B3.34B3.43B
Operating Expenses3.33B3.25B3.44B3.49B3.58B
Depreciation & Amortization4.64B4.2B3.82B3.78B3.76B
EBITDA9.92B10.66B11.92B12.38B13.02B
EBITDA Margin32.2%32.0%36.3%37.5%38.3%
Operating Income5.28B6.46B8.11B8.6B9.25B
Operating Margin17.2%19.4%24.7%26.0%27.2%
Interest Income40M117M197M228M209M
Interest Expense159M192M488M572M464M
Other Income / Expenses(65M)(745M)50M144M(207M)
Income Before Tax5.22B5.72B8.16B8.74B9.05B
Pre-Tax Margin16.9%17.1%24.8%26.5%26.6%
Income Tax Expense1.26B1.43B1.81B2B1.99B
Net Income3.83B4.15B6.2B6.57B6.9B
Net Margin12.4%12.4%18.9%19.9%20.3%
EPS (Basic)7.408.3012.7013.7114.67
EPS (Diluted)7.338.2312.5913.6214.59
Weighted Avg Shares516.9M499.74M488.19M478.77M466.25M
Weighted Avg Shares (Diluted)521.88M504.04M492.29M482.09M468.7M

Linde plc

NASDAQ:LIN

Intrinsic Alpha fair value

Locked

Current Price

$512.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.